Advertisement
UK markets close in 4 hours 41 minutes

  • FTSE 100

    8,094.57
    +54.19 (+0.67%)
     

  • FTSE 250

    19,704.41
    -14.96 (-0.08%)
     

  • AIM

    755.16
    +0.47 (+0.06%)
     

  • GBP/EUR

    1.1665
    +0.0020 (+0.18%)
     

  • GBP/USD

    1.2513
    +0.0050 (+0.40%)
     

  • Bitcoin GBP

    50,824.09
    -2,183.90 (-4.12%)
     

  • CMC Crypto 200

    1,349.64
    -32.93 (-2.38%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CRUDE OIL

    82.88
    +0.07 (+0.08%)
     

  • GOLD FUTURES

    2,337.50
    -0.90 (-0.04%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     

  • DAX

    17,978.65
    -110.05 (-0.61%)
     

  • CAC 40

    8,029.13
    -62.73 (-0.78%)
     
Stocks:

Trending tickers

Microsoft, Alphabet, Anglo American, IBM, Astrazeneca, Unilever and Sainsbury's

Indivior settles addiction treatment case with Mylan for undisclosed terms

Reuters - UK Focus

Sept 25 (Reuters) - Indivior (Frankfurt: 2IVA.F - news) 's U.S. subsidiary, together with Monosol Rx, has settled a patent dispute with U.S. drugmaker Mylan (Hamburg: 27249935.HM - news) related to generic versions of its opioid addiction treatment Suboxone, which generates 80 percent of the Indivior's revenue.

The terms of the settlement are confidential, the London-listed drugmaker said in a statement on Monday.

The litigation has been pending in a U.S. after Mylan filed an application to the U.S. FDA seeking approval to market generic versions of Suboxone delivered by dissolvable film placed under the tongue rather than by tablet.

Other than Mylan, lawsuits were filed earlier this month against Dr. Reddy's, Allergan Plc (Frankfurt: A1W5NE - news) 's Actavis Laboratories, Endo International (NasdaqGS: ENDP - news) 's Par Pharmaceutical, Alvogen Pharma US and Teva Pharmaceutical Industries . (Reporting by Justin George Varghese in Bengaluru, editing by Louise Heavens)